Milan, Italy · Founded 2009 · Privately Held (backing)
Developer of a medical platform designed to provide a targeted approach in the treatment of cancer. BetaGlue Therapeutics is based in Milan, Italy and was founded in 2009. Its last reported valuation was $25.3 million in Jul 2022. It has raised $49 million.
Last reported valuation
$25.3M
Oct 2026
Priced at
—
Total raised
$49.0M
Last round
—
Team — not yet on record
No current team members for BetaGlue Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BetaGlue Therapeutics with a free account
·The complete investor list: 14 names
·Watch BetaGlue Therapeutics: the Monday email on marks, rounds and moves
